Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-22 | Mr. Swisher is CEO of Sunesis Pharmaceuticals and Chairman of Cerus Corporation, with a B.A. from Yale University and an M.B.A. from Stanford Graduate School of Business. |
| 2017-04-21 | Daniel N. Swisher, Jr. became a member of our Board in June 2015. He has been the Chief Executive Officer and a member of the Board of Sunesis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, since 2003, and its President since 2005. Mr. Swisher holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. |
| 2018-04-24 | Daniel N. Swisher, Jr. became a member of our Board in June 2015. He has been the President and Chief Operating Officer of Jazz Pharmaceuticals since January 2018. From 2003 to December 2017, he was Chief Executive Officer and a member of the board of directors of Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company. He joined Sunesis in 2001 and had previously served as the company’s chief business officer and chief financial officer. |
| 2019-04-24 | Daniel N. Swisher, Jr. is President and COO of Jazz Pharmaceuticals and former CEO of Sunesis Pharmaceuticals. He holds a B.A. from Yale and an M.B.A. from Stanford Graduate School of Business. |
| 2020-04-27 | Mr. Swisher received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance. |
| 2021-04-22 | Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance. |
| 2022-04-25 | Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance. |
| 2023-04-14 | Mr. Swisher has been the President of Jazz Pharmaceuticals and CEO of Sunesis Pharmaceuticals, a clinical-stage biopharmaceutical company. He received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. |
| 2024-04-10 | Mr. Swisher received his B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in pharmaceutical industry development, sales, marketing, operations and finance. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-08-30 | Daniel N. Swisher, Jr. included in the list of directors with no indication of software or technical background. |
Data sourced from SEC filings. Last updated: 2026-02-03